Literature DB >> 17131045

Direct evidence that two cysteines in the dopamine transporter form a disulfide bond.

Rong Chen1, Hua Wei, Erik R Hill, Lucy Chen, Liying Jiang, Dawn D Han, Howard H Gu.   

Abstract

We have generated a fully functional dopamine transporter (DAT) mutant (dmDATx7) with all cysteines removed except the two cysteines in extracellular loop 2 (EL2). Random mutagenesis at either or both EL2 cysteines did not produce any functional transporter mutants, suggesting that the two cysteines cannot be replaced by any other amino acids. The cysteine-specific reagent MTSEA-biotin labeled dmDATx7 only after a DTT treatment which reduces disulfide bond. Since there are no other cysteines in dmDATx7, the MTSEA-biotin labeling must be on the EL2 cysteines made available by the DTT treatment. This result provides the first direct evidence that the EL2 cysteines form a disulfide bond. Interestingly, the DTT treatment had little effect on transport activity suggesting that the disulfide bond is not necessary for the uptake function of DAT. Our results and previous results are consistent with the notion that the disulfide bond between EL2 cysteines is required for DAT biosynthesis and/or its delivery to the cell surface.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17131045     DOI: 10.1007/s11010-006-9348-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.842


  18 in total

Review 1.  Anti-hyperactivity medication: methylphenidate and amphetamine.

Authors:  P Seeman; B K Madras
Journal:  Mol Psychiatry       Date:  1998-09       Impact factor: 15.992

Review 2.  Molecular characterization of the dopamine transporter.

Authors:  B Giros; M G Caron
Journal:  Trends Pharmacol Sci       Date:  1993-02       Impact factor: 14.819

Review 3.  Neurotransmitter transporters: three distinct gene families.

Authors:  S G Amara; J L Arriza
Journal:  Curr Opin Neurobiol       Date:  1993-06       Impact factor: 6.627

Review 4.  From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters.

Authors:  G Rudnick; J Clark
Journal:  Biochim Biophys Acta       Date:  1993-10-04

5.  Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment.

Authors:  H Hastrup; A Karlin; J A Javitch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

6.  External cysteine residues in the serotonin transporter.

Authors:  J G Chen; S Liu-Chen; G Rudnick
Journal:  Biochemistry       Date:  1997-02-11       Impact factor: 3.162

7.  Cocaine affinity decreased by mutations of aromatic residue phenylalanine 105 in the transmembrane domain 2 of dopamine transporter.

Authors:  Xiaohong Wu; Howard H Gu
Journal:  Mol Pharmacol       Date:  2003-03       Impact factor: 4.436

8.  Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence.

Authors:  H Gu; S C Wall; G Rudnick
Journal:  J Biol Chem       Date:  1994-03-11       Impact factor: 5.157

Review 9.  Pharmacokinetics of second generation antidepressants: bupropion.

Authors:  P J Goodnick
Journal:  Psychopharmacol Bull       Date:  1991

10.  Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.

Authors:  Dawn D Han; Howard H Gu
Journal:  BMC Pharmacol       Date:  2006-03-03
View more
  25 in total

1.  Interaction of tyrosine 151 in norepinephrine transporter with the 2β group of cocaine analog RTI-113.

Authors:  Erik R Hill; Xiaoqin Huang; Chang-Guo Zhan; F Ivy Carroll; Howard H Gu
Journal:  Neuropharmacology       Date:  2011-03-21       Impact factor: 5.250

2.  Molecular basis of the dopaminergic system in the cricket Gryllus bimaculatus.

Authors:  Takayuki Watanabe; Hisayo Sadamoto; Hitoshi Aonuma
Journal:  Invert Neurosci       Date:  2013-03-29

3.  Discrepancy in Insulin Regulation between Gestational Diabetes Mellitus (GDM) Platelets and Placenta.

Authors:  Yicong Li; Anthonya Cooper; Imelda N Odibo; Asli Ahmed; Pamela Murphy; Ruston Koonce; Nafisa K Dajani; Curtis L Lowery; Drucilla J Roberts; Luc Maroteaux; Fusun Kilic
Journal:  J Biol Chem       Date:  2016-02-26       Impact factor: 5.157

4.  Using In Vivo Electrochemistry to Study the Physiological Effects of Cocaine and Other Stimulants on the Drosophila melanogaster Dopamine Transporter.

Authors:  Monique A Makos; Kyung-An Han; Michael L Heien; Andrew G Ewing
Journal:  ACS Chem Neurosci       Date:  2010-01-20       Impact factor: 4.418

5.  Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding.

Authors:  Weimin C Hong; Susan G Amara
Journal:  J Biol Chem       Date:  2010-08-05       Impact factor: 5.157

6.  Comparative modeling of the human monoamine transporters: similarities in substrate binding.

Authors:  Heidi Koldsø; Anja B Christiansen; Steffen Sinning; Birgit Schiøtt
Journal:  ACS Chem Neurosci       Date:  2012-11-08       Impact factor: 4.418

7.  The role of cysteines and histidins of the norepinephrine transporter.

Authors:  Birger Wenge; Heinz Bönisch
Journal:  Neurochem Res       Date:  2013-03-23       Impact factor: 3.996

8.  Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations.

Authors:  Xiaoqin Huang; Howard H Gu; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2009-11-12       Impact factor: 2.991

9.  N-Ethylmaleimide differentially inhibits substrate uptake by and ligand binding to the noradrenaline transporter.

Authors:  Birger Wenge; Heinz Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-03-21       Impact factor: 3.000

10.  The Role of skn-1 in methylmercury-induced latent dopaminergic neurodegeneration.

Authors:  Ebany J Martinez-Finley; Samuel Caito; James C Slaughter; Michael Aschner
Journal:  Neurochem Res       Date:  2013-11-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.